Lexology January 26, 2024
In anticipation of the US Food and Drug Administration (FDA) budget request for Fiscal Year (FY) 2025, this alert provides an overview of the agency’s most recent priorities as outlined in FDA’s FY 2024 budget, found here. This alert allows clients and stakeholders to review current year FDA priorities to indicate potential new areas of regulation and enforcement. The alert is part one of a two-part series and will be updated when the FDA releases its FY2025 priorities to identify changes in priorities from FY2024 to FY2025.
Broadly, FDA’s goals aim to enhance and expand FDA’s authority and oversight, as well as build upon and create new programs with regard to foods, dietary supplements, human and animal drugs, animal biologics,...
Today's Sponsors
Today's Sponsor